AI Article Synopsis
- Streptomyces ambofaciens ATCC23877 is a soil bacterium used in industry to produce spiramycin, an antibacterial and anti-toxoplasmosis drug.
- Its genome features an 8.3 Mbp linear chromosome and an 89 kb circular plasmid.
- The complete genome sequence allows for research into genome evolution and the discovery of new secondary metabolites for potential medical use.
Article Abstract
Streptomyces ambofaciens ATCC23877 is a soil bacterium industrially exploited for the production of the macrolide spiramycin which is used in human medicine as an antibacterial and anti-toxoplasmosis chemical. Its genome consists of a 8.3 Mbp linear chromosome and a 89 kb circular plasmid. The complete genome sequence reported here will enable us to investigate Streptomyces genome evolution and to discover new secondary metabolites with potential applications notably in human medicine.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jbiotec.2015.09.020 | DOI Listing |
Publication Analysis
Top Keywords
complete genome
8
genome sequence
8
streptomyces ambofaciens
8
human medicine
8
sequence streptomyces
4
ambofaciens atcc
4
atcc 23877
4
23877 spiramycin
4
spiramycin producer
4
producer streptomyces
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!